T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.19% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 10.74% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXRT
1176
NexPoint Residential Trust
NXRT
$631M
| $24.4M | ﹤0.01% |
270,348
+6,261
| +2% | +$522K |
|
1177
FS Bancorp
FSBW
$325M
| $24.4M | ﹤0.01% |
786,518
-6,780
| -0.9% | -$221K |
|
|
EVRI
1178
DELISTED
Everi Holdings
EVRI
| $24.2M | ﹤0.01% |
1,153,584
+182,970
| +19% | +$3.9M |
|
1179
Adient
ADNT
$1.44B
| $24.1M | ﹤0.01% |
590,871
-81,978
| -12% | -$3.52M |
|
1180
AES
AES
$10.5B
| $24.1M | ﹤0.01% |
935,297
-7,287,520
| -89% | -$165M |
|
1181
UDR
UDR
$12B
| $23.8M | ﹤0.01% |
415,251
-20,212
| -5% | -$1.15M |
|
|
ZNGA
1182
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $23.8M | ﹤0.01% |
2,574,180
-57,967,772
| -96% | -$509M |
|
1183
Rigetti Computing
RGTI
$6.21B
| $23.8M | ﹤0.01% |
3,898,000
+2,500,000
| +179% | +$22.3M |
|
1184
Quest Diagnostics
DGX
$26.2B
| $23.7M | ﹤0.01% |
173,493
-11,297
| -6% | -$1.57M |
|
|
K
1185
DELISTED
Kellanova
K
| $23.7M | ﹤0.01% |
392,100
-16,993
| -4% | -$1.02M |
|
1186
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $23.7M | ﹤0.01% |
+288,100
| New | +$24.1M |
|
1187
IDEAYA Biosciences
IDYA
$3.56B
| $23.7M | ﹤0.01% |
2,114,993
-586,532
| -22% | -$8.65M |
|
1188
Entrada Therapeutics
TRDA
$299M
| $23.4M | ﹤0.01% |
2,494,714
+474,077
| +23% | +$5.08M |
|
1189
Rapid Micro Biosystems
RPID
$84.8M
| $23.4M | ﹤0.01% |
3,447,186
+1,247,440
| +57% | +$9.19M |
|
1190
Clearway Energy Class C
CWEN
$7.06B
| $23.4M | ﹤0.01% |
640,100
-111,932
| -15% | -$3.81M |
|
1191
Immuneering
IMRX
$328M
| $23.1M | ﹤0.01% |
3,565,473
+376,968
| +12% | +$3.62M |
|
1192
Carnival Corporation Ltd
CCL
$38.9B
| $23.1M | ﹤0.01% |
1,140,350
-63,281
| -5% | -$1.28M |
|
1193
Array Technologies
ARRY
$799M
| $22.9M | ﹤0.01% |
2,034,914
+902,616
| +80% | +$10.1M |
|
1194
Evergy
EVRG
$19.2B
| $22.8M | ﹤0.01% |
333,624
-15,297
| -4% | -$987K |
|
1195
Braze
BRZE
$3.12B
| $22.7M | ﹤0.01% |
548,570
-223,019
| -29% | -$11.2M |
|
1196
LGI Homes
LGIH
$1.32B
| $22.7M | ﹤0.01% |
232,681
-166,705
| -42% | -$20.6M |
|
|
CNTA
1197
DELISTED
Centessa Pharmaceuticals
CNTA
| $22.7M | ﹤0.01% |
2,528,583
+451,813
| +22% | +$4.12M |
|
1198
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $22.6M | ﹤0.01% |
+50,100
| New | +$22.3M |
|
|
ABCM
1199
DELISTED
Abcam PLC
ABCM
| $22.5M | ﹤0.01% |
1,229,454
+21,521
| +2% | +$381K |
|
1200
Williams-Sonoma
WSM
$28.9B
| $22.4M | ﹤0.01% |
309,274
+4,070
| +1% | +$308K |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.